TSA vs RSA in Glenohumeral Osteoarthritis
ConditionOsteoarthritis of the Shoulder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorOttawa Hospital Research Institute
About this trial
This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.
Eligibility criteria
Qualifiers
The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
Activity modification
Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
Disqualifiers
Active joint or systemic infection
Rotator cuff arthropathy
Significant muscle paralysis
Charcot's arthropathy
Trial design
Treatments tested in this trial
- Total Shoulder Arthroplasty
- Reverse Shoulder Arthroplasty
Treatment groups
108 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov